இதய வடிகுழாய் ஆய்வகங்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from இதய வடிகுழாய் ஆய்வகங்கள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In இதய வடிகுழாய் ஆய்வகங்கள் Today - Breaking & Trending Today

Raj Tayal, MD of the Cardiac Catheterization Laboratories for Valley Health System Named NJ Top Doc


Raj Tayal, MD of the Cardiac Catheterization Laboratories for Valley Health System Named NJ Top Doc
Share Article
Board Certified Cardiologist, Dr. Rajiv Tayal has been reviewed and approved by NJ Top Docs for 2021.
Raj Tayal, MD
We are dedicated to improving and maintaining health not only through preventive care but also by offering cutting-edge cardiac care with the latest advances in equipment, therapies, and options to participate in a number of National Clinical Trials.
SCOTCH PLAINS, N.J. (PRWEB)
May 22, 2021
NJ Top Docs has reviewed and approved Dr. Rajiv Tayal for 2021. Dr. Tayal is the Director of the Cardiac Catheterization Laboratories for the Valley Health System, in Ridgewood, NJ. He is a board certified cardiologist specializing in interventional cardiology and structural heart disease. ....

New Jersey , United States , Scotch Plains , Raj Tayal , Rajiv Tayal , National Clinical Trials , Catheterization Laboratories For The Valley Health System , National Clinical , Cardiac Catheterization Laboratories , Valley Health System , Assistant Professor , New York Medical , Principal Investigator , Future Leader , Young Leader , Interventional Cardiology , Master Faculty , Coronary Artery , Myocardial Protected , Top Doctors , United States Top Docs , Press Release , புதியது ஜெர்சி , ஒன்றுபட்டது மாநிலங்களில் , ஸ்காட்ச் சமவெளி , தேசிய மருத்துவ சோதனைகள் ,

Novel technology can be effective non-surgical treatment option for congenital heart disease patients


Novel technology can be effective non-surgical treatment option for congenital heart disease patients
New study results validate the effectiveness of the Medtronic Harmony™ transcatheter pulmonary valve (TPV) system for patients with congenital heart disease (CHD) and severe pulmonary regurgitation (PR). The Harmony TPV is designed to be a less invasive treatment option for patients with irregularity in their right ventricular outflow tract (RVOT) needing pulmonary valve placement to restore valve function. The results of this study are being presented as late-breaking clinical science today at the Society for Cardiovascular Angiography & Interventions (SCAI) 2021 Scientific Sessions.
About 40,000 infants are born with CHD every year in the United States and approximately one in five CHD patients have an abnormality of their right ventricular outflow tract (RVOT) . Prior to TPV technology, CHD patients were treated with invasive procedures such as open-heart surgery or o ....

United States , Thomas Jones , Emily Henderson , Society For Cardiovascular Angiography Interventions , Drug Administration , Medtronic Harmony , Cardiovascular Angiography , Principal Investigator , Cardiac Catheterization Laboratories , Seattle Children , Congenital Heart Disease , Heart Disease , ஒன்றுபட்டது மாநிலங்களில் , தாமஸ் ஜோன்ஸ் , எமிலி ஹென்டர்சன் , சமூகம் க்கு இருதய ஆஞ்சியோகிராபி தலையீடுகள் , மெதிடிறோனிக் நல்லிணக்கம் , இருதய ஆஞ்சியோகிராபி , ப்ரிந்ஸிபல் புலனாய்வாளர் , இதய வடிகுழாய் ஆய்வகங்கள் , சீட்டில் குழந்தைகள் , பிறவி இதயம் நோய் ,

Technology provides non-invasive treatment for congenital heart disease patients


 E-Mail
WASHINGTON, D.C., (April 30, 2021) - New study results validate the effectiveness of the Medtronic Harmony™ transcatheter pulmonary valve (TPV) system for patients with congenital heart disease (CHD) and severe pulmonary regurgitation (PR). The Harmony TPV is designed to be a less invasive treatment option for patients with irregularity in their right ventricular outflow tract (RVOT) needing pulmonary valve placement to restore valve function. The results of this study are being presented as late-breaking clinical science today at the Society for Cardiovascular Angiography & Interventions (SCAI) 2021 Scientific Sessions.
About 40,000 infants are born with CHD every year in the United States and approximately one in five CHD patients have an abnormality of their right ventricular outflow tract (RVOT) . Prior to TPV technology, CHD patients were treated with invasive procedures such as open-heart surgery or opted for surgical valve replacement later in life. Th ....

United States , Thomas Jones , Society For Cardiovascular Angiography Interventions , Drug Administration , Society For Cardiovascular Angiography , Medtronic Harmony , Cardiovascular Angiography , Principal Investigator , Cardiac Catheterization Laboratories , Seattle Children , ஒன்றுபட்டது மாநிலங்களில் , தாமஸ் ஜோன்ஸ் , சமூகம் க்கு இருதய ஆஞ்சியோகிராபி தலையீடுகள் , சமூகம் க்கு இருதய ஆஞ்சியோகிராபி , மெதிடிறோனிக் நல்லிணக்கம் , இருதய ஆஞ்சியோகிராபி , ப்ரிந்ஸிபல் புலனாய்வாளர் , இதய வடிகுழாய் ஆய்வகங்கள் , சீட்டில் குழந்தைகள் ,